The response of cyclic 3',5'-AMP and cyclic 3',5'-GMP phosphodiesterases to experimental diabetes
- PMID: 6249634
- DOI: 10.1007/BF01978592
The response of cyclic 3',5'-AMP and cyclic 3',5'-GMP phosphodiesterases to experimental diabetes
Abstract
Alloxan diabetes caused a decrease in cyclic AMP phosphodiesterase in all affected rat tissues. Cyclic GMP phosphodiesterase activity was, however, decreased in adipose and liver, but increased increased in heart and uterus.
Similar articles
-
Cyclic nucleotides and cyclic nucleotide phosphodiesterases in kidneys from rats with experimental diabetes.Res Commun Chem Pathol Pharmacol. 1981 Aug;33(2):381-4. Res Commun Chem Pathol Pharmacol. 1981. PMID: 6272381
-
Regulation of specific forms of cyclic nucleotide phosphodiesterases in cultured cells.Adv Cyclic Nucleotide Protein Phosphorylation Res. 1984;16:291-301. Adv Cyclic Nucleotide Protein Phosphorylation Res. 1984. PMID: 6326529 No abstract available.
-
Activation of rat cerebral cortical 3',5'-cyclic nucleotide phosphodiesterase activity by gangliosides.Mol Pharmacol. 1980 Mar;17(2):206-11. Mol Pharmacol. 1980. PMID: 6248757 No abstract available.
-
The role of protein phosphorylation in the regulation of cyclic nucleotide phosphodiesterases.Mol Cell Biochem. 1993 Nov;127-128:239-53. doi: 10.1007/BF01076775. Mol Cell Biochem. 1993. PMID: 7935355 Review.
-
[Phosphodiesterases of cyclic GMP].Postepy Hig Med Dosw. 2001;55(5):611-27. Postepy Hig Med Dosw. 2001. PMID: 11795198 Review. Polish.
Cited by
-
Identification of the molecular basis for phosphorylase hypersensitivity in cultured diabetic cardiomyocytes.Mol Cell Biochem. 1995 Apr 26;145(2):131-9. doi: 10.1007/BF00935485. Mol Cell Biochem. 1995. PMID: 7675033